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With Coronary Artery Dilation and With Laboratory
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Objectives We explored the association of noncoronary cardiac abnormalities with coronary artery dilation and with labora-
tory inflammatory markers early after Kawasaki disease (KD) diagnosis.
Background Left ventricular (LV) dysfunction, mitral regurgitation (MR), and aortic root dilation occur early after diagnosis;
their associations with coronary artery dilation and inflammatory markers have not been well-described.
Methods Centrally interpreted echocardiograms were obtained at KD diagnosis and 1 and 5 weeks after diagnosis on 198
subjects in the National Institutes of Health-sponsored Pediatric Heart Network KD pulsed steroid trial. Regres-
sion models were constructed to investigate the relationships among early LV dysfunction, MR, and aortic root
dilation with coronary artery dilation and laboratory inflammatory markers.
Results At diagnosis, LV systolic dysfunction was present in 20% of subjects and was associated with coronary artery
dilation, seen in 29% (p  0.004). Although LV dysfunction improved rapidly, LV dysfunction at diagnosis pre-
dicted greater odds of coronary artery dilation at 1 and 5 weeks after diagnosis (5-week odds ratio: 2.7, 95%
confidence interval: 1.2 to 6.3). At diagnosis, MR was present in 27% of subjects and aortic root dilation was
present in 8%; each was associated with larger coronary artery size at diagnosis. Left ventricular dysfunction was
associated with higher erythrocyte sedimentation rate and, at diagnosis only, lower serum albumin; MR was as-
sociated with higher erythrocyte sedimentation rate and lower albumin at all times. Aortic root size had little
association with inflammatory markers.
Conclusions Noncoronary cardiac abnormalities are associated with coronary artery dilation and laboratory evidence of in-
flammation in the first 5 weeks after KD, suggesting a shared inflammatory mechanism. (Trial of Pulse Steroid
Therapy in Kawasaki Disease [A Trial Conducted by the Pediatric Heart Network]; NCT00132080) (J Am Coll
Cardiol 2011;57:86–92) © 2011 by the American College of Cardiology Foundation
ublished by Elsevier Inc. doi:10.1016/j.jacc.2010.08.619d
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Tawasaki disease (KD) is an acute, self-limited febrile
llness of unknown etiology. Although coronary artery
equelae are responsible for the major morbidity and mor-
ality of KD, acute KD is often accompanied by noncoro-
ary cardiac abnormalities, including left ventricular (LV)
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ortic root dilation (1-7). Both the vasculitis that leads to
oronary artery sequelae and these noncoronary cardiac
bnormalities might be consequences of an initial immune-
ediated response (1,8-11). Although prior studies have
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December 28, 2010/January 4, 2011:86–92 Cardiac Abnormalities in Acute Kawasaki Diseaseonfirmed a relationship between inflammatory changes in
cute KD and the risk of coronary artery dilation (12-18),
o consistent relation has been found between LV dysfunc-
ion, valvar regurgitation, and aortic root dilation and
oronary artery dilation or systemic inflammatory markers
4-7,9,19-21). The existence of such a relation might have
echanistic implications for understanding KD and its
onsequences.
We sought to analyze the relationship between echocar-
iographic evidence of noncoronary cardiac abnormalities
ith coronary artery dilation and echocardiographic evi-
ence of noncoronary cardiac abnormalities with markers of
ystemic inflammation during the first 5 weeks after KD
iagnosis. We hypothesized that: 1) noncoronary cardiac
bnormalities and coronary artery abnormalities are correlated
arly after KD diagnosis; and 2) LV systolic dysfunction, mitral
egurgitation (MR), and aortic root dilation in acute KD are
ssociated with laboratory evidence of systemic inflammation.
ethods
he National Heart, Lung, and Blood Institute-sponsored
ediatric Heart Network multicenter, prospective, random-
zed trial of pulsed steroid therapy in primary treatment of
D produced a well-characterized database of clinical data
nd centrally interpreted echocardiographic findings at the
ime of KD diagnosis (baseline) and at 1 and 5 weeks after
iagnosis (22). We used the KD trial database to analyze the
elationships of LV systolic dysfunction, the incidence of
R, and aortic root dimension with coronary artery dilation
nd with systemic inflammatory markers. Trial eligibility,
nrollment, and procedures have been reported (22). Briefly,
etween December 2002 and December 2004, 199 consent-
ng subjects from 8 North American centers who met
pecific study criteria for KD (1,23) and were between days
and 10 of illness were enrolled at the time of KD
iagnosis. One subject withdrew shortly after consent, and
o echocardiograms were submitted. Mean age of the 198
emaining subjects was 3.3  2.2 years (16% under 1 year),
nd 63% were boys. Two subjects who met KD diagnostic
riteria were later identified as having had herpes simplex
irus and Ebstein-Barr virus, respectively; these subjects
emain in the dataset, although their exclusion did not affect
he results. The study was approved by the institutional
eview board or ethics committee of each center.
chocardiographic methods. Echocardiograms were per-
ormed with pre-specified protocol guidelines (22); children
nable to cooperate were sedated according to local practice.
ll baseline echocardiograms were performed within 48 h of
rial randomization. Follow-up echocardiograms were per-
ormed 1 week (mean 7.8 1.8 days, n 198) and 5 weeks
mean 36.5  4.3 days, n  195) after randomization.
chocardiograms were centrally interpreted by a single core
aboratory reviewer who was blinded to subject identity,
reatment group, and illness day. Measurements of LV
imensions, LV fractional shortening (FS), aortic root dimen- cion, and coronary artery segment
iameters were made. The severity
f valvar regurgitation was qual-
tatively assessed by color Dopp-
er imaging, with notation made
f there was at least mild MR or
ortic regurgitation. A pericardial
ffusion was considered present if
ts maximal dimension was at least
mm in any imaging plane.
VFS, aortic root dimension,
nd the incidence of valvar re-
urgitation and of pericardial
ffusion were reported as part of
he trial results (22).
Echocardiographic measure-
ents of LV dimensions, aortic
oot dimension, and proximal
eft anterior descending and right coronary artery segments
ere transformed to z-scores (SD U) on the basis of body
urface area (BSA) (12). Maximum coronary artery z-score
as defined as the greater of the z-scores relative to BSA of
ither the proximal left anterior descending or right coro-
ary artery segment. Coronary artery dilation was defined as
resent if the maximum coronary artery z-score of the
ubject was2. Normal values for LVFS are age-dependent
24). For this reason, LV systolic dysfunction was defined as
n age-adjusted LVFS z-score2 (i.e., a LVFS measure-
ent that was more than 2 SDs below the mean for age).
tatistical methods. Data from both KD trial arms were
ombined for this study analysis, because there were no
ifferences in echocardiographic parameters between treat-
ent groups (22). An exploratory analysis was performed to
ssess whether baseline LVFS varied according to timing of
he baseline echocardiogram with respect to intravenous
mmune globulin (IVIG) infusion (i.e., whether the echo-
ardiogram was performed before, the day of, or after
VIG); because no correlation was found, this was not
xplored further (Online Appendix).
Longitudinal mixed model regression analyses were con-
ucted that examined the association between LVFS
-score and continuous maximum coronary artery z-score
nd the association between aortic root size and maximum
oronary artery z-score. Interactions with study visit (time)
ere fit to assess the existence of differential correlations by
ime.
Logistic regression was used to determine whether the
resence versus absence of baseline LV dysfunction, MR, or
ortic root dilation could predict those subjects who had
oronary artery dilation (defined as z-score 2) at baseline
nd at 1- and 5-week follow-up.
Multivariate longitudinal mixed regression models were
onstructed for 3 outcomes: LVFS z-score, aortic root
-score, and the presence of MR to estimate associations
ith laboratory measures of inflammation: white blood
Abbreviations
and Acronyms
BSA  body surface area
CI  confidence interval
CRP  C-reactive protein
ESR  erythrocyte
sedimentation rate
FS  fractional shortening
IVIG  intravenous immune
globulin
KD  Kawasaki disease
LV  left ventricular
MR  mitral regurgitation
OR  odds ratio
WBC  white blood countount (WBC), erythrocyte sedimentation rate (ESR),
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Cardiac Abnormalities in Acute Kawasaki Disease December 28, 2010/January 4, 2011:86–92-reactive protein (CRP), albumin concentration, platelet
ount, hemoglobin concentration, hematocrit, and neutro-
hil count. Several clinical variables, including time since
andomization (study visit), sex, and age, were also evalu-
ted as potential correlates. Interactions between study visit
nd laboratory measures were examined. For all analyses, we
onsidered p  0.05 to represent a significant association.
esults
V systolic dysfunction and coronary artery dilation in
cute KD. At baseline, mean LVFS z-score was significantly
ower than expected for a normal age-matched population, and
V dysfunction (age-adjusted LVFS z-score 2) was
resent in 20% of subjects (Tables 1 and 2). Left ventricular
unction improved rapidly over time; among subjects defined as
aving LV dysfunction at baseline, 89% had normal LV
ystolic function by Week 5. Baseline LV end-diastolic and
nd-systolic dimension z-scores were higher than normal,
ndicating ventricular dilation (Table 1).
Longitudinal mixed regression modeling found a weak
ut significant inverse association between FS z-score and
aximum coronary artery z-score across all time points: for
ach unit increase in FS z-score, coronary artery z-score
ecreased 0.05 U (n  559 observations on 198 subjects,
stimated slope  SE 0.051  0.024, p  0.033) (i.e.,
etter LV systolic function was associated with smaller
oronary artery z-scores). There were also significant but
eak correlations between LV end-diastolic and end-
ystolic dimensions with maximal coronary artery z-score at
aseline; these correlations were weaker or nonexistent at
ollow-up.
Echocardiographic Parameters by Time Since RTable 1 Echocardiographic Para eters by T
Parameter Baseline
LVFS (%) 36.0 6.2 (189)
LVFS z-score 0.32 2.22* (189
LV end-diastolic dimension z-score 0.54 1.16† (189
LV end-systolic dimension z-score 0.45 1.54† (189
Aortic root z-score 0.81 0.85† (162
Maximum coronary artery z-score 1.65 1.48† (195
Values are mean SD (number of observations). Differs significantly fr
from longitudinal model assessing linear change over time.
ercentage of Subjects Withbnorm l Echocardiographic ValuesTable 2 Percenta e of Subject WithAbnormal Echocardiographic Values
Parameter Baseline Week 1 Week 5
LVFS z-score 2 20% (189) 4% (186) 10% (185)
Aortic root z-score 2 8% (162) 9% (169) 10% (175)
Maximum coronary artery
z-score 2
29% (195) 29% (190) 18% (190)
Mitral regurgitation 27% (193) 15% (197) 9% (195)
Aortic regurgitation 1% (191) 1% (197) 1% (195)
Pericardial effusion 2% (195) 3% (195) 0% (195)VFS  left ventricular fractional shortening.Patients with LV dysfunction at baseline, compared with
hose with normal LV function, had greater odds of having
oronary artery dilation at baseline (odds ratio [OR]: 2.9,
5% confidence interval [CI]: 1.4 to 6.2, p  0.004) and at
week (OR: 2.5, 95% CI: 1.1 to 6.3, p  0.016) and
-week follow-up (OR: 2.7, 95% CI: 1.2 to 6.1, p  0.019)
Fig. 1). Thus, the presence of LV dysfunction at baseline
redicted baseline and early convalescent (1- and 5-week)
oronary artery dilation.
As noted in Newburger et al. (22), there were 4 patients
ho developed coronary artery dilation 4 mm in any
oronary artery segment (“aneurysm”), excluding potentially
re-existing, isolated left main coronary artery abnormalities
n 2 patients; none developed “giant” (8 mm) aneurysms.
hree of 4 patients who developed aneurysms had severe
aseline LV dysfunction, with FS z-scores of 3.8, 5.8,
2.9, and 1.4. Increased baseline LVFS z-score was pro-
ective against development of a coronary artery aneurysm
OR: 0.62/U increase in z-score, 95% CI: 0.40 to 0.97, p 
.035).
izationince Randomization
Week 1 Week 5 p Value
38.7 5.0 (186) 37.8 5.4 (185) NS
0.70 1.65† (186) 0.38 1.93† (185) 0.001
0.28 1.20‡ (186) 0.31 1.14† (185) 0.007
0.20 1.34* (185) 0.04 1.32 (185) 0.001
0.94 0.82† (169) 0.84 0.87† (175) 0.129
1.73 1.83† (190) 1.35 1.81† (190) 0.001
mal population mean, *p 0.05; †p 0.001; ‡p 0.01. The p value
Figure 1 Coronary Artery Dilation by Initial LVFS z-Score
Odds ratio (OR): p  0.002 at baseline; p  0.016 at Week 1; p  0.019 at
Week 5. The ORs shown here are from logistic regression models with maxi-
mum coronary artery z-score 2 as the outcome. LVFS  left ventricular frac-
tional shortening.andomime S
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December 28, 2010/January 4, 2011:86–92 Cardiac Abnormalities in Acute Kawasaki Diseasessociation of LV systolic dysfunction with laboratory
nd clinical markers. Table 3 presents a multivariate
odel for LVFS z-score incorporating the 3 independent
orrelates of LV systolic dysfunction: higher ESR (at all
ime points; p  0.007), higher WBC (at 1- and 5-week
ollow-up; p  0.047 and p  0.048, respectively), and
ower serum albumin concentration (at baseline; p 0.028).
RP was inversely correlated with LVFS z-score in univar-
ate analysis (p  0.044), but because CRP and albumin
ere correlated in this dataset, CRP did not remain as an
ndependent correlate of LVFS z-score in the multivariate
odel.
resence of MR and coronary artery dilation. At least
ild MR was noted in 27% of subjects on their baseline
chocardiogram; the incidence of MR rapidly decreased by
- and 5-week follow-up (Table 2) (p 0.0001). No subject
ad severe MR. Subjects with MR at baseline had greater
aseline coronary artery size when compared with those
ubjects without baseline MR (mean maximum coronary
rtery z-score 1.99 1.57 vs. 1.51 1.42, respectively, p
.04), as seen in Figure 2. Unlike LV dysfunction at
aseline, the presence of MR at baseline did not predict
oronary artery dilation or the presence of coronary artery
neurysms at follow-up.
ssociation of the presence of MR with laboratory and
linical markers. Table 4 presents the multivariate model
or the presence of MR versus clinical/laboratory data.
levated ESR (p  0.020), lower albumin (p  0.003), and
emale sex (p  0.019) were independently correlated with
he presence of MR, regardless of study visit. After adjust-
ent for laboratory values, there remained a trend toward
n inverse association between the presence of MR and
tudy visit (p  0.068). Mitral regurgitation did not
orrelate with CRP, WBC, or degree of anemia.
ortic root and coronary artery dilation in acute KD.
ean aortic root z-scores were significantly higher than
ormal at baseline and at 1- and 5-week follow-up, with
%, 9%, and 10% of subjects found to have aortic root
ultivariate Model for LVFS z-ScoreTable 3 ultivariate Model for LVFS z-Score
Variable Slope  SE p Value
ESR, mm/h 0.009 0.003 0.007
WBC (103/mm3)  visit 0.033
Week 0 0.016 0.03 0.561
Week 1 0.079 0.04 0.047
Week 5 0.11 0.06 0.048
Albumin (g/dl)  visit 0.008
Week 0 0.51 0.23 0.028
Week 1 0.47 0.34 0.172
Week 5 0.66 0.42 0.117
he model is based on analysis of 507 echocardiograms from 3 time points (visits). Due to the
resence of interactions between laboratory parameters and visit, main effect estimates for these
erms in the model are not shown.
LVFS  left ventricular fractional shortening.-scores at or above 2 at baseline and 1 and 5 weeks,
iespectively (Tables 1 and 2). Aortic root z-scores did not
ary significantly between study visits.
Longitudinal mixed regression modeling of the associa-
ion between aortic root and coronary artery size at all time
oints revealed a moderate association between maximum
oronary artery z-score and aortic root z-score: for every
-U increase in aortic root z-score, maximum coronary
rtery z-score increased by 0.3 U (n  505 observations on
93 subjects, estimated slope  SE: 0.30  0.08, p 
.0003). There was no interaction with study visit, indicat-
ng that the association exists at all time points.
ssociation of aortic root size versus laboratory and
linical markers. In a multivariate model constructed ex-
loring associations of aortic root size, there were significant
ndependent effects of time (aortic root z-score highest at
aseline; p  0.017) and sex (aortic root z-score higher for
oys, 1.04  0.07 vs. 0.52  0.09 for girls; p  0.0001).
here were 2 marginal associations between aortic root size
Figure 2 Maximum Coronary Artery z-Score at
Baseline by Mitral Regurgitation Status at Baseline
The diamond denotes the mean, lower and upper edges of the box denote the
25th and 75th quartiles, and the center line in the box denotes the median.
p  0.04.
ultivariate Model for Presence Versusbsence of at Least Mild Mitral R gurgitationTable 4 ultivariate Model for Pre ence VersusAbsence of at Least Mild Mitral Regurgitation
Variable Odds Ratio 95% CI p Value
Visit 0.068
Week 0 vs. Week 1 1.70 1.04–2.79 0.035
Week 0 vs. Week 5 1.14 0.52–2.51 0.739
Week 1 vs. Week 5 1.49 0.34–1.32 0.248
Female 2.02 1.12–3.66 0.019
ESR, mm/h 1.48* 1.06–2.07 0.020
Albumin, g/dl 0.40 0.22–0.73 0.003
odel is based on analysis of 527 echocardiograms from 3 time points (visits). *Per 50-U increase
n erythrocyte sedimentation rate (ESR).
CI  confidence interval.
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Cardiac Abnormalities in Acute Kawasaki Disease December 28, 2010/January 4, 2011:86–92nd laboratory inflammatory markers: there was a weak
ositive correlation between albumin and aortic root z-score
t baseline only (p  0.052), and there was a trend toward
positive correlation between ESR and aortic root size (p
.093), with a 0.2-U increase in aortic root z-score per each
00-mm/h increase in ESR.
iscussion
e found that noncoronary cardiac abnormalities, includ-
ng early LV systolic dysfunction, the presence of MR, and
ortic root dilation, are common in acute KD and are
ssociated with coronary artery dilation during the first 5
eeks after KD diagnosis. Acute LV systolic dysfunction
nd the presence of MR are associated with laboratory
vidence of inflammation, including elevated ESR and
ecreased serum albumin, whereas aortic root dilation
hows little correlation with these markers. These findings
uggest that noncoronary cardiac abnormalities and coro-
ary artery dilation in acute KD share a common but
omplex etiologic mechanism that relates to systemic in-
ammation. Further investigation of this mechanism might
elp in understanding the long-term consequences of KD,
hich might not be isolated to those subjects with signifi-
ant residual coronary artery dilation (25).
Histological evidence of cardiac inflammation has been
emonstrated in almost all subjects with acute KD when
ssessed by endomyocardial biopsy (26), and in a majority of
ubjects when assessed by WBC-labeled radionuclide stud-
es (27-29); acute LV dysfunction has also been reported
4,5,28-30). We detected a 20% incidence of acute LV
ysfunction; prior investigators detected a higher incidence
f LV dysfunction (5), but this and prior studies were based
n different definitions of ventricular dysfunction or used
entricular function assessment techniques not widely avail-
ble in clinical practice. Acute LV dysfunction in KD is
ypically transient, as opposed to late onset or chronic LV
ysfunction that might result from coronary insufficiency
nd/or myocardial fibrosis. We detected a rapid improve-
ent in LV function, similar to prior studies (4,5), within 1
eek of IVIG therapy. Rapid improvement in LV function
s unique when compared with other etiologies of myocar-
itis in which function improves more slowly and less consis-
ently. This rapid LV function improvement has led some
nvestigators to postulate that acute LV dysfunction in KD is
odulated by immune-mediated processes related to neutral-
zation of circulating toxins or activated cytokines (5).
Prior studies have failed to consistently establish an
ssociation between LV dysfunction and coronary artery
ilation, despite the high prevalence of LV dysfunction early
fter KD diagnosis. Hsu et al. (29) found that patients with
arditis (as diagnosed by abnormal radionuclide-labeled
BC scans) had lower ejection fractions and larger coro-
ary arteries when assessed within 1 week of KD diagnosis.
n contrast, Anderson et al. (31) and Newburger et al. (4)
ound no relationship between LV dysfunction and coro- pary artery dilation in acute KD. These 2 studies used
apanese Ministry of Health criteria for coronary abnormal-
ties (23) rather than the more sensitive BSA-adjusted
oronary artery z-scores (32) used in our current study; this
ight explain why we detected an association between LV
ysfunction and coronary artery dilation while prior studies
id not.
We found ESR, WBC, and albumin to be associated
ith LV dysfunction at some or all time points in the first
weeks of illness. Few prior studies have demonstrated any
ssociation between systemic inflammatory indexes and LV
ysfunction. Newburger et al (4) did not detect any relation
etween LV function and laboratory inflammatory markers.
oran et al. (5) also found no association between baseline
evels of acute phase reactants and LV contractility but did
emonstrate concordance between clinical and myocardial
esponse to IVIG therapy. Yoshikawa et al. (33) found that
V dysfunction was associated with an increase in CRP in
of 4 KD subjects assessed but only after IVIG infusion.
gain, these differences might be attributable to differing
ethods of LV function assessment.
Mild or moderate MR occurred in approximately one-
uarter of subjects and was associated with laboratory
vidence of acute inflammation. To the best of our knowl-
dge, our study is the first to demonstrate an association
etween acute MR and laboratory inflammatory markers.
Our incidence of acute MR (27%) was similar to the 23%
eported by Giddings et al. (20) but lower than the 47%
eported by Suzuki et al. (34). These differences might
e because different treatment eras were examined or because
ualitative rather than quantitative definitions of MR were
mployed. Mechanisms for MR in acute KD might also be
ifferent from mechanisms for MR present after the acute KD
pisode (35). Our study did not investigate the mechanism of
R or its persistence beyond 5 weeks after acute KD.
Aortic root dilation was associated with coronary artery
ilation early after KD diagnosis. The degree of aortic root
ilation that we found early after KD diagnosis was similar
o that reported by Ravekes et al. (7). They did not detect
ny association between aortic root dilation and coronary
rtery dilation, but BSA-adjusted coronary artery z-scores
ere not examined. Our study and Ravekes et al. (7) showed
hat the degree of aortic root dilation remained constant
etween Weeks 1 and 5 after KD diagnosis. We could not
onfirm their finding that aortic root dilation persisted 1
ear after KD, because our patients were not followed
eyond Week 5.
Our finding of a weak correlation between larger baseline
ortic root size and higher serum albumin (in contrast to the
orrelation between baseline LV dysfunction and lower serum
lbumin) is consistent with there being a different temporal
ourse and/or etiology for these 2 findings. These differences
uggest that LV dysfunction, MR, aortic root dilation, and
oronary artery dilation might share slightly different inflam-
atory mechanisms. As noted by Ravekes et al. (7), priorathologic studies have suggested that microvascular vasculitis
(
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December 28, 2010/January 4, 2011:86–92 Cardiac Abnormalities in Acute Kawasaki Diseaserelating to coronary artery dilation) occurs within 10 days of
D onset, whereas vasculitis involving larger arteries (poten-
ially relating to aortic root dilation) occurs on Days 12 to 25
nto the course of KD. An alternate explanation for the
emporal differences of aortic root and coronary artery dilation
ight be a limited capacity for great artery remodeling,
erhaps because there is more connective tissue and less
uscularization of the aortic wall. Further research into these
ifferences might help in understanding the long-term vascular
equelae of KD.
We found that acute MR was more common in girls with
D, whereas aortic root size adjusted for BSA was larger in
oys. These observations have not been demonstrated pre-
iously, although male sex has been associated with “higher-
isk” KD. It is unclear whether sex differences represent
iffering genetic susceptibilities to inflammatory responses
n acute KD or whether these differences are spurious. This
s another area that might relate to potential long-term
ardiovascular effects of KD.
Although 20% of subjects had baseline LV dysfunction,
o subject was coded by site investigators to have congestive
eart failure, perhaps because this would have been difficult
o differentiate from symptoms like tachycardia and tachy-
nea due to fever, anemia, and/or dehydration. Also, be-
ause identification of congestive heart failure was not a trial
im, coding for congestive heart failure could have been
ncomplete. Similarly, many acute KD patients have heart
urmurs due to fever and anemia; the presence of an MR
urmur was not assessed during this trial.
tudy limitations. Because the randomized trial of pulsed
teroids in KD was designed to evaluate acute changes
ssociated with treatment, long-term follow-up is not avail-
ble. All patients in this study were treated with IVIG
ithin the first 10 days of illness onset, and there were few
atients with coronary artery aneurysms; it is possible that
he associations between cardiac and laboratory parameters
ight have been even stronger in a sicker group of children.
inally, this study has reported correlations between param-
ters but cannot establish causality.
onclusions
oncoronary cardiac abnormalities are associated with cor-
nary artery dilation and with laboratory evidence of inflam-
ation in the first 5 weeks after KD diagnosis. Future
tudies should explore shared inflammatory mechanisms
hat might underlie these associations and help in under-
tanding the long-term consequences of KD.
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